Lumos Diagnostics Holdings Limited

LDX

AU0000157091

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 04:10:03 17/04/26 pm AEST			5-day change	1st Jan Change
0.1950 ^AUD	+5.41%		+11.43%	-31.58%

14/04	Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care	MT
14/04	Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%	MT

Lumos Diagnostics Holdings secures contract to manufacture Micro-Pak mold analyzer system

Published on 04/08/2026 at 11:19 am AEST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Lumos Diagnostics Holdings Limited

14/04	Lumos Diagnostics Expands FebriDx Test Rollout at WellStreet Urgent Care	MT
14/04	Lumos Diagnostics Receives $5 Million Prepayment From US Distribution Partner, Shares Up 3%	MT
08/04	Lumos Diagnostics Holdings secures contract to manufacture Micro-Pak mold analyzer system	RE
08/04	Lumos Diagnostics Secures Three-Year Contract to Manufacture Mold Analyzer; Shares Up 3%	MT
01/04	Lumos Diagnostics Holdings Receives Largest Ever Purchase Order of $1.3 Million, Shares Up 9%	MT
01/04	Lumos Diagnostics receives largest FebriDx order to date	RE
31/03	Lumos Diagnostics Holdings Limited - Special Call
27/03	Lumos Diagnostics to Raise AU$20 Million via Share Placement	MT
27/03	Lumos Diagnostics announces share purchase plan to raise about A$2.0 million	RE
27/03	Lumos Diagnostics says US FDA grants CLIA waiver for FebriDx	RE
25/03	Lumos Diagnostics seeks trading halt pending update on FDA response	RE
03/03	Lumos Diagnostics Holdings Limited, H1 2026 Earnings Call, Mar 03, 2026
27/02	Lumos Diagnostics loss for half-year attributable $4.9 million	RE
27/02	Lumos Diagnostics Holdings Fiscal H1 Revenue Falls Slightly; Shares Up 3%	MT
27/02	Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI

Chart Lumos Diagnostics Holdings Limited

Duration

Period

Chart Lumos Diagnostics Holdings Limited

LDX: Dynamic Chart

Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections and ViraDx, a three-in-one POC test for influenza A, influenza B and COVID-19. Its services include assay development, reader development, cloud and data, and manufacturing. It manages the full development program for POC assays.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

20/04 - Earnings release - Q3 2026

More about the company